ℹ️
🇬🇧
Search
Search for people relevant for "Staging"
Staging
Person
Class
Person
Publication
Programmes
Export current view
doc. MUDr. Martin Svatoň Ph.D.
Academic staff at Faculty of Medicine in Pilsen
82 publications
Publications
publication
Real-life effectiveness of first-line anticancer treatments in stage IIIB/IV NSCLC patients: Data from the Czech TULUNG Registry
2020 |
Faculty of Medicine in Pilsen, First Faculty of Medicine, Central Library of Charles University
publication
Correlation of Iodine Quantification and FDG Uptake in Early Therapy Response Assessment of Non-small Cell Lung Cancer: Possible Benefit of Dual-energy CT Scan as an Integral Part of PET/CT Examination
2020 |
Faculty of Medicine in Pilsen
publication
Effect of clinical parameters on second- and third-line erlotinib treatment of EGFR wild type patients with advanced NSCLC
2019 |
Faculty of Medicine in Pilsen, First Faculty of Medicine, Second Faculty of Medicine, Central Library of Charles University
publication
Current review of immunotherapy and anti-angiogenic lung cancer treatment
2019 |
Faculty of Medicine in Pilsen
publication
Effects of Treatment with Crizotinib on Non-small Cell Lung Carcinoma with ALK Translocation in the Czech Republic
2018 |
Faculty of Medicine in Pilsen, Faculty of Medicine in Hradec Králové, First Faculty of Medicine, Second Faculty of Medicine
publication
Predictive relevance of miR-34a, miR-224 and miR-342 in patients with advanced squamous cell carcinoma of the lung undergoing palliative chemotherapy
2018 |
Faculty of Medicine in Pilsen
publication
Thyroid transcription factor 1 expression is associated with outcome of patients with non-squamous non-small cell lung cancer treated with pemetrexed-based chemotherapy
2017 |
Faculty of Medicine in Pilsen, Faculty of Medicine in Hradec Králové
publication
Influence of expression of selected genes encoding proteins and microRNA on the risk of stage 1 pulmonary adenocarcinoma relapse
2017 |
Faculty of Medicine in Pilsen
publication
Change in Serum Lactate Dehydrogenase Is Associated with Outcome of Patients with Advanced-stage NSCLC Treated with Erlotinib
2016 |
Faculty of Medicine in Pilsen, Faculty of Science, First Faculty of Medicine
publication
Pemetrexed Versus Erlotinib in the Second-line Treatment of Patients with Advanced-stage Non-squamous NSCLC Harboring Wild-type EGFR Gene
2016 |
Faculty of Medicine in Pilsen, Faculty of Science
Load more publications (72)
Loading network view...